Print this page |
 |
Below table shows the anticancer properties of various kinds of mushrooms.
Source: the Faculty of Medicine, the University of Tokyo, the National Cancer Center Research Center and the Tokyo University of Pharmacy. |
 |

|
 Name of mushroom
|
 Dosage/kg/Day
|
 Rate of complete recovery
|
 Anticancer effect
|
 |

|
Agaricus blazei Murill |
10mg |
90.0% |
99.4% |
 |
 |

|
Grifola umbellata |
10mg |
90.0% |
98.5% |
 |
 |

|
Phellinus yucatensis |
30mg |
87.5% |
96.5% |
 |
 |

|
Phellinus igniarius |
30mg |
66.7% |
87.4% |
 |
 |

|
Lenxites betulina |
30mg |
57.1% |
70.2% |
 |
 |

|
Tricholoma matsutake |
30mg |
55.5% |
91.3% |
 |
 |

|
Lentinus edodes |
30mg |
54.5% |
80.7% |
 |
 |

|
Coriolus versicolor |
30mg |
50.0% |
77.5% |
 |
 |

|
Pleurotus osteatus |
30mg |
45.5% |
75.3% |
 |
 |

|
Elfringia applanata |
30mg |
45.5% |
64.9% |
 |
 |

|
Fomitopsis pincicola |
30mg |
33.3% |
61.2% |
 |
 |

|
Fomitopsis cytisna |
30mg |
30.3% |
44.2% |
 |
 |

|
Pholiota nameko |
30mg |
30.0% |
86.5% |
 |
 |

|
Flammulina velutipes |
30mg |
30.0% |
81.1% |
 |
 |

|
Ganoderma lucidum |
30mg |
20.0% |
77.8% |
 |
|
|
|
Copyright © 2013 Healfinity Pharmaceutical. All rights reserved.
|